Positive Impact

01424 851 375

Introducing NEW
Lash Builder from the makers of DemEx

Why Lash Builder is different

Your patients are bombarded with online offerings of products which, although effective in lash-regeneration, may also exacerbate their underlying dry eye condition.
Lash Builder offers a gentle and easy to use alternative to the currently available eyelash serums which often incorporate sub-optimal ingredients.

Lash Builder is free from harsh preservatives including benzalkonium chloride (BAK) which is known to be cytotoxic to the cornea.

Lash Builder does not use a PGA based active ingredients (or their synthetic derivatives) to avoid the dry eye symptom increase associated with glaucoma eye drops using these actives.

How to use Lash Builder

Lash Builder comes in an easy-to-use 15ml pump bottle, each pump delivers sufficient clear gel for both eyes.
Dramatic improvements in eyelash and eyebrow volume, length and thickness are typically seen after 6-8 weeks.

Use a small bead of gel every night

Apply to clean closed eyes

Do not rinse off

Leave over night

Lash Builder helps restore eyelashes and eyebrow hairs while you sleep

This highly innovative formulation works using a biomimetic peptise, acetyl-tetrapeptide-3 and red clover extract which impact lash loss in three ways: 

1. Suppresses testosterone – linked to hair loss

2. Increases estrogen – promotes hair growth

3. Supports the hair follicle by increasing collagen

Find out more about
Lash Builder

Our Downloads

Interested in using Lash Builder in your practice?

Contact us to find out more about Lash Builder and to order.

T: 01424 851 375

References:
1. Mertzanis P, Venkataraman K, Begley C, Chalmers R, Abetz L. The Impact of Dry Eye on Daily Life: Results from a Qualitative Study. Investigative
Ophthalmology & Visual Science December 2002, Vol.43, 74.
2. Kitazawa M, Sakamoto C, Yoshimura M, Kawashima M, Inoue S, Mimura M, Tsubota K, Negishi K, Kishimoto T. The Relationship of Dry Eye Disease with
Depression and Anxiety: A Naturalistic Observational Study. Transl Vis Sci Technol. 2018 Dec 28;7(6):35. doi: 10.1167/tvst.7.6.35. PMID: 30619655; PMCID: PMC6314109.
3. Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang JH, Yco L, Sonawane S, Khanolkar V, Hallak J, Jain S. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1792-802. doi: 10.1167/iovs.11-8775. PMID: 22410563; PMCID: PMC3995561.
4. Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang JH, Yco L, Sonawane S, Khanolkar V, Hallak J, Jain S. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1792-802. doi: 10.1167/iovs.11-8775. PMID: 22410563; PMCID: PMC3995561.

Read the news on
Positive Impact

Webinar: The Use of Heat in Managing MGD

Join Nick Atkins in this CPD webinar as he explores effective heat delivery options for managing MGD. Gain insights into both in-practice and at-home solutions to enhance your practice’s MGD management strategies.

Learn More
Two choices with easy empirical fitting

Positive Impact (PI) has launched two new contact lenses in the UK, Alexa high resolution AR, offering a…

Learn More
Our Annual Christmas Food Donation

In the true spirit of the season, we are thrilled to share a heartwarming tradition that has become…

Learn More